Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HBB | P68871 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18751690 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HBBHSD17B10GRM2 | |
| SCHEMBL18751689 | 0.88 | POLB (0.34) | ALDH1A1HBBHSD17B10 | |
| SCHEMBL12355150 | 0.86 | ALDH1A1 (0.30) | ALDH1A1HBBHSD17B10 | |
| SCHEMBL10031821 | 0.86 | GRM2 (0.31) | ALDH1A1HBBHSD17B10GRM2 | |
| SCHEMBL13661861 | 0.84 | BTK (0.38) | ALDH1A1HSD17B10 | |
| SCHEMBL25530270 | 0.84 | EPHX1 (0.31) | — | |
| SCHEMBL16501734 | 0.82 | BTK (0.30) | — | |
| SCHEMBL18751739 | 0.82 | CHRNB2 (0.38) | — | |
| SCHEMBL16704552 | 0.81 | POLB (0.37) | ALDH1A1HBBHSD17B10 | |
| SCHEMBL18751737 | 0.81 | POLB (0.37) | ALDH1A1HBBHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12479873-B2 | Metal complexes | UDC Ireland (IE) | 2025-11-25 | — | — | US | disclosed |
| CN-114249639-B | Method for efficiently and selectively catalyzing degradation cyclization of polyketone (ester) | 复旦大学 | 2023-12-22 | — | — | CN | disclosed |
| US-20230322826-A1 | METAL COMPLEXES | UDC IRELAND LIMITED (IE) | 2023-10-12 | — | — | US | disclosed |
| US-11713332-B2 | Metal complexes | MERCK PATENT GMBH (DE) | 2023-08-01 | — | — | US | disclosed |
| CN-114249639-A | Method for efficiently catalyzing degradation cyclization of polypropylene ketone (ester) with high selectivity | 复旦大学 | 2022-03-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12479873-B2 | Metal complexes | AP1M1, SOD1, AP3M1 | ALDH1A1 3754/4885HBB 3081/4885HSD17B10 2799/4885 |
| US-11713332-B2 | Metal complexes | AP1M1, SOD1, AP3M1 | ALDH1A1 3754/4885HBB 3081/4885HSD17B10 2799/4885 |
| US-20230322826-A1 | METAL COMPLEXES | AP1M1, SOD1, AP3M1 | ALDH1A1 3754/4885HBB 3081/4885HSD17B10 2799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.